Ark Bio
Singapore, Singapore
Ark is an end-to-end solution provider focused on cancer early detection. By harnessing advanced data science and proprietary miRNA detection technology, Ark develops non-invasive and cost-effective blood tests to detect early stage cancers before clinical symptoms appear. The company collaborates extensively with top medical research institutions globally and is spearheading Asia’s largest miRNA clinical studies targeting more than 50,000 participants. Ark is headquartered in Singapore, with R&D, manufacturing and clinical diagnostic operations in China and USA. Ark was founded in early 2018 through the merger of MiRXES and Venturecraft
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- ark.bio
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Ark Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now